Taking The Regulatory Path Of Most Resistance
Source: Cytiva
Why is taking the most stringent regulatory path forward a sound strategy in a multijurisdictional global filing effort? Find out in this segment of the Bioprocess Online Live event Regulatory Harmonization Meets CMC Realities. Chief Editor Matt Pillar, Alira Health Senior VP of CMC Steven Chamow, Ph.D., and Steffi Pluschkell, Ph.D., former Pfizer Head of Business Strategy and Operations and current CEO of InScope Coaching & Consulting consider the pros and cons of the approach.
access the Virtual Event!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more